AZD1222 (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "AZD1222" in Japanese language version.

refsWebsite

Global rank Japanese rank

18wikipedia.org

low place

low place

49^th place

67^th place

4^th place

24^th place

2^nd place

6^th place

8^th place

73^rd place

5astrazeneca.com

low place

low place

20^th place

100^th place

7^th place

63^rd place

68^th place

425^th place

432^nd place

1,191^st place

4web.archive.org

1^st place

1^st place

613^th place

1,897^th place

79^th place

235^th place

5^th place

19^th place

3theguardian.com

12^th place

120^th place

3bangkokpost.com

1,173^rd place

3,865^th place

99^th place

542^nd place

8,771^st place

low place

2japantoday.com

3,795^th place

5,742^nd place

137^th place

1,092^nd place

220^th place

1,047^th place

2thedailystar.net

593^rd place

8,134^th place

129^th place

896^th place

2fiercepharma.com

low place

low place

2koreatimes.co.kr

536^th place

2,725^th place

3,984^th place

low place

low place

low place

1astrazeneca.co.jp

low place

low place

28^th place

188^th place

1clinicaltrials.gov

5,225^th place

low place

1clinicaltrialsregister.eu

low place

low place

211^th place

13^th place

low place

4,955^th place

1covid19vaccinetrial.co.uk

low place

low place

692^nd place

43^rd place

1newsweekjapan.jp

4,574^th place

296^th place

low place

low place

476^th place

4,439^th place

2,740^th place

6,964^th place

62^nd place

911^th place

234^th place

363^rd place

18^th place

107^th place

2,393^rd place

4,709^th place

1creativecommons.org

1,010^th place

4,166^th place

1independent.co.uk

36^th place

268^th place

1hungarytoday.hu

low place

low place

1hindustantimes.com

71^st place

2,422^nd place

3,255^th place

low place

2,412^th place

low place

74^th place

2,015^th place

117^th place

47^th place

low place

low place

981^st place

386^th place

290^th place

1,589^th place

491^st place

2,918^th place

484^th place

2,490^th place

1indiatimes.com

17^th place

799^th place

1financialexpress.com

798^th place

low place

low place

low place

481^st place

2,184^th place

1marketwatch.com

1,303^rd place

4,167^th place

494^th place

5,998^th place

115^th place

741^st place

1,712^th place

7,476^th place

1,485^th place

1,610^th place

279^th place

2,509^th place

1matichon.co.th

2,552^nd place

low place

6,364^th place

low place

1thairath.co.th

1,304^th place

low place

1thestandard.co

4,613^th place

low place

low place

low place

437^th place

2,588^th place

1,309^th place

5,169^th place

low place

low place

78^th place

1,525^th place

638^th place

37^th place

7day.news

“Myanmar will get doses for 15 million people this February”. 7day.news. https://7day.news/301094 8 January 2021閲覧。

admin.ch

“COVID-19 vaccine: Swiss federal government signs agreement with AstraZeneca”. www.admin.ch. 16 October 2020閲覧。

afpbb.com

“EU、アストラゼネカ提訴ワクチン供給契約の違反主張”. AFP (2021年4月27日). 2021年4月27日閲覧。

apnews.com

“Sri Lanka approves vaccine amid warnings of virus spread”. AP NEWS (2021年1月22日). 2021年1月22日閲覧。
“EU tightens vaccine export rules, creates post-Brexit outcry” (30 January 2021). 2022年2月22日閲覧。

astrazeneca.co.jp

「アストラゼネカの新型コロナウイルス感染症（COVID-19）に関わる取り組みについて」アストラゼネカ公式サイト 2020年4月24日付（2020年12月24日更新）、2021年3月1日閲覧.

astrazeneca.com

"AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19". Press Release (Press release). AstraZeneca. 23 November 2020. 2021年1月5日閲覧。
"AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19". AstraZeneca (Press release). 2020年11月27日閲覧。
"FDA authorises restart of the COVID-19 AZD1222 vaccine US Phase III trial". AstraZeneca (Press release). 2020年12月1日閲覧。
"COVID-19 Vaccine AstraZeneca confirms 100% protection against severe disease, hospitalisation and death in the primary analysis of Phase III trials". Press Release (Press release). AstraZeneca. 3 February 2021. 2021年2月18日閲覧。
So AD, Woo J (December 2020). “Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis”. BMJ 371: m4750. doi:10.1136/bmj.m4750. PMC 7735431. PMID 33323376. cited "Agreements with CEPI and Gavi and the Serum Institute of India will bring vaccine to low and middle-income countries and beyond" (Press release). AstraZeneca. 4 June 2020.

bangkokpost.com

bbc.co.uk

“Covid-19: Oxford-AstraZeneca coronavirus vaccine approved for use in UK”. BBC News. BBC (30 December 2020). 30 December 2020閲覧。
“Covid: Brian Pinker, 82, first to get Oxford-AstraZeneca vaccine”. BBC News. BBC (4 January 2021). 4 January 2021閲覧。
“Oxford/AstraZeneca Covid vaccine 'dose error' explained”. BBC News. (27 November 2020) 27 November 2020閲覧。
Triggle N (8 February 2021). “Covid: Are fears over Oxford-AstraZeneca jab justified?” 9 February 2021閲覧。
“Covid: Boris Johnson 'very confident' in vaccines being used in UK”. (8 February 2021) 9 February 2021閲覧。
“AstraZeneca to begin making vaccine”. BBC (5 June 2020). 1 July 2020閲覧。

bbc.com

bloomberg.com

canada.ca

Health Canada (Oct 2, 2020). “Health Canada begins first authorization review of a COVID-19 vaccine submission”. gcnws. Dec 30, 2020閲覧。

cbc.ca

“With no successful vaccine candidates yet, Canada signs deal to secure 20M more COVID-19 vaccine doses”. CBC News (2020年9月25日). 2022年2月22日閲覧。

clinicaltrials.gov

“Investigating a Vaccine Against COVID-19”. ClinicalTrials.gov. United States National Library of Medicine (26 May 2020). 11 October 2020時点のオリジナルよりアーカイブ。14 July 2020閲覧。

clinicaltrialsregister.eu

“A Phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19”. EU Clinical Trials Register. European Union (21 April 2020). 5 October 2020時点のオリジナルよりアーカイブ。3 August 2020閲覧。

cnbc.com

Ellyatt H (2021年2月8日). “AstraZeneca races to adapt Covid vaccine as South Africa suspends rollout” (英語). CNBC. 2021年2月8日閲覧。
“South Africa halts AstraZeneca vaccinations after data shows little protection against mutation” (英語). CNBC (2021年2月7日). 2021年2月8日閲覧。

cnn.com

edition.cnn.com

Walsh N, Shelley J, Duwe E, Bonnett W (27 July 2020). “The world's hopes for a coronavirus vaccine may run in these health care workers' veins”. CNN (São Paulo). オリジナルの3 August 2020時点におけるアーカイブ。 3 August 2020閲覧。

covid19vaccinetrial.co.uk

“COVID-19 Vaccine Trials | COVID-19”. covid19vaccinetrial.co.uk. 2020年4月11日閲覧。

creativecommons.org

“Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet”. 9 December 2020閲覧。 This article incorporates text by Voysey et al. available under the CC BY 4.0 license.

doi.org

O'Reilly P (26 May 2020). A Phase III study to investigate a vaccine against COVID-19. doi:10.1186/ISRCTN89951424. ISRCTN89951424.
Arashkia A, Jalilvand S, Mohajel N, Afchangi A, Azadmanesh K, Salehi-Vaziri M, Fazlalipour M, Pouriayevali MH, Jalali T, Mousavi Nasab SD, Roohvand F, Shoja (2020). “Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects”. Reviews in Medical Virology n/a (n/a): e2183. doi:10.1002/rmv.2183. PMC 7646037. PMID 33594794.
Wang H, Yang P, Liu K, Guo F, Zhang Y, Zhang G, Jiang C (February 2008). “SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway”. Cell Research 18 (2): 290–301. doi:10.1038/cr.2008.15. PMC 7091891. PMID 18227861.
Callaway E (23 November 2020). “Why Oxford's positive COVID vaccine results are puzzling scientists”. Nature 588 (7836): 16–18. Bibcode: 2020Natur.588...16C. doi:10.1038/d41586-020-03326-w. PMID 33230278.
Wise J (February 2021). “Covid-19: The E484K mutation and the risks it poses”. BMJ 372: n359. doi:10.1136/bmj.n359. PMID 33547053.
So AD, Woo J (December 2020). “Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis”. BMJ 371: m4750. doi:10.1136/bmj.m4750. PMC 7735431. PMID 33323376. cited "Agreements with CEPI and Gavi and the Serum Institute of India will bring vaccine to low and middle-income countries and beyond" (Press release). AstraZeneca. 4 June 2020.

efe.com

Agencia EFE Staff (31 December 2020). “La República Dominicana aprueba la vacuna de AstraZeneca contra la covid-19” (スペイン語). Agencia EFE

europa.eu

ema.europa.eu

ec.europa.eu

"European Commission authorises third safe and effective vaccine against COVID-19". European Commission (Press release). 2021年1月29日閲覧。
“COVID-19 Vaccine AstraZeneca”. Union Register of medicinal products. 18 February 2021閲覧。

fiercepharma.com

“AstraZeneca, Emergent BioSolutions sign $87M deal to produce U.S. supply of COVID-19 vaccine”. FiercePharma. 12 June 2020閲覧。
“AstraZeneca taps Catalent for COVID-19 vaccine finishing, packaging at Italian plant”. FiercePharma. 16 June 2020閲覧。

financialexpress.com

Kumar M (7 August 2020). “Covid-19 vaccine: Serum Institute signs up for 100 million doses of vaccines for India, low and middle-income countries”. The Financial Express

france24.com

“Covid-19: France, Italy, Germany and Netherlands sign vaccine deal for Europe”. France 24 (13 June 2020). 15 June 2020閲覧。

gavi.org

So & Woo (2020), p. 3 cited "New collaboration makes further 100 million doses of COVID-19 vaccine available to low- and middle- income countries" (Press release). Gavi, the Vaccine Alliance. 29 September 2020.^{[リンク切れ]}

globo.com

g1.globo.com

Voluntário brasileiro que participava dos testes da vacina de Oxford e morreu com a Covid era médico e ex-aluno da UFRJ, Globo

gob.mx

Comisión Federal para la Protección contra Riesgos Sanitarios. “AUTORIZACIÓN PARA USO DE EMERGENCIA A VACUNA ASTRAZENECA COVID-19” (スペイン語). gob.mx 7 January 2021閲覧。

gov.uk

“Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca”. Medicines and Healthcare products Regulatory Agency (MHRA) (30 December 2020). 4 January 2021閲覧。
“Conditions of Authorisation for COVID-19 Vaccine AstraZeneca”. Medicines and Healthcare products Regulatory Agency (MHRA) (30 December 2020). 4 January 2021閲覧。
“Government asks regulator to approve supply of Oxford/AstraZeneca vaccine”. GOV.UK. Department of Health and Social Care (27 October 2020). 2020年11月28日閲覧。
“Oxford University/AstraZeneca vaccine authorised by UK medicines regulator”. Gov.uk. Department of Health and Social Care (30 December 2020). 30 December 2020閲覧。

harvard.edu

ui.adsabs.harvard.edu

Callaway E (23 November 2020). “Why Oxford's positive COVID vaccine results are puzzling scientists”. Nature 588 (7836): 16–18. Bibcode: 2020Natur.588...16C. doi:10.1038/d41586-020-03326-w. PMID 33230278.

hfocus.org

“ข่าวดี! ไทยจองซื้อวัคซีนโควิด-19 แอสตราเซเนกา "ราคาต้นทุน"”. hfocus.org (2020年11月23日). 2020年11月23日時点のオリジナルよりアーカイブ。2022年2月22日閲覧。

hindustantimes.com

Gaurav K (1 January 2021). “Govt's expert panel approves AstraZeneca/Oxford Covid-19 vaccine for emergency use”. Hindustan Times

hungarytoday.hu

“Everything You Need to Know About the Oxford-AstraZeneca Vaccine” (January 23, 2021). 2022年2月22日閲覧。

independent.co.uk

“Oxford vaccine researchers have found 'winning formula', AstraZeneca chief says”. The Independent. 27 December 2020閲覧。

indiatimes.com

economictimes.indiatimes.com

Rajagopal D (4 June 2020). “AstraZeneca & Serum Institute of India sign licensing deal for 1 billion doses of Oxford vaccine”. The Economic Times

inquirer.net

newsinfo.inquirer.net

“Over 200 firms to ink deal for more COVID vaccines with gov't, AstraZeneca”. INQUIRER.NET. (2021年1月11日)

itv.com

Peston R (2021年1月26日). “What is the dispute between the EU and AstraZeneca over Covid jabs?”. ITV News. 2021年1月27日閲覧。

japantoday.com

“AstraZeneca resumes vaccine trial in talks with US”. Japan Today (3 October 2020). 2022年2月22日閲覧。
“AstraZeneca agrees to supply Europe with 400 mil doses of COVID-19 vaccine”. Japan Today. 15 June 2020閲覧。

jiji.com

「厚労省、ワクチン供給で英大手と合意 1.2億回分、来年初めにも―新型コロナ」時事ドットコム 2020年8月7日付、2021年2月26日閲覧.

khn.org

“They Pledged to Donate Rights to Their COVID Vaccine, Then Sold Them to Pharma”. Kaiser Health News. 28 January 2021閲覧。

koreatimes.co.kr

marketwatch.com

Calatayud A. “AstraZeneca to supply Europe with Covid-19 vaccine”. MarketWatch. 15 June 2020閲覧。

matichon.co.th

“ทำความรู้จัก ออกซ์ฟอร์ด-แอสทราเซเนกา วัคซีนที่ไทยเลือก” (タイ語). มติชนออนไลน์. (2021年1月2日) 2021年1月5日閲覧。

mfds.go.kr

“아스트라제네카社 코로나19 백신 품목허가” (朝鮮語). 식품의약품안전처. 식품의약품안전처 (2021年2月10日). 2021年2月10日閲覧。

msn.com

“Taiwan grants emergency authorisation for AstraZeneca COVID-19 vaccine”. www.msn.com. 2021年2月22日閲覧。

nasdaq.com

“AZN, IQV Team Up To Accelerate COVID-19 Vaccine Work, RIGL's ITP Drug Repurposed, IMV On Watch”. RTTNews. 15 July 2020閲覧。

nature.com

Callaway E (23 November 2020). “Why Oxford's positive COVID vaccine results are puzzling scientists”. Nature 588 (7836): 16–18. Bibcode: 2020Natur.588...16C. doi:10.1038/d41586-020-03326-w. PMID 33230278.

nbcnews.com

“'What's the deal?' Researchers in paused vaccine trial search for answers.”. NBC News. 2022年2月22日閲覧。
“Volunteer in AstraZeneca Covid-19 vaccine trial dies in Brazil”. NBC News. 2022年2月22日閲覧。

news24.com

Felix J (7 January 2021). “SA will get 1 million doses of Covid-19 vaccine from India this month”. News24.com 7 January 2021閲覧。

newsweekjapan.jp

「日本政府、アストラゼネカとコロナワクチン1.2億回分供給で最終合意」『ニューズウィーク日本版』 2020年12月11日付、2021年3月1日閲覧.

nih.gov

pubmed.ncbi.nlm.nih.gov

Arashkia A, Jalilvand S, Mohajel N, Afchangi A, Azadmanesh K, Salehi-Vaziri M, Fazlalipour M, Pouriayevali MH, Jalali T, Mousavi Nasab SD, Roohvand F, Shoja (2020). “Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects”. Reviews in Medical Virology n/a (n/a): e2183. doi:10.1002/rmv.2183. PMC 7646037. PMID 33594794.
Wang H, Yang P, Liu K, Guo F, Zhang Y, Zhang G, Jiang C (February 2008). “SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway”. Cell Research 18 (2): 290–301. doi:10.1038/cr.2008.15. PMC 7091891. PMID 18227861.
Callaway E (23 November 2020). “Why Oxford's positive COVID vaccine results are puzzling scientists”. Nature 588 (7836): 16–18. Bibcode: 2020Natur.588...16C. doi:10.1038/d41586-020-03326-w. PMID 33230278.
Wise J (February 2021). “Covid-19: The E484K mutation and the risks it poses”. BMJ 372: n359. doi:10.1136/bmj.n359. PMID 33547053.
So AD, Woo J (December 2020). “Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis”. BMJ 371: m4750. doi:10.1136/bmj.m4750. PMC 7735431. PMID 33323376. cited "Agreements with CEPI and Gavi and the Serum Institute of India will bring vaccine to low and middle-income countries and beyond" (Press release). AstraZeneca. 4 June 2020.

ncbi.nlm.nih.gov

Arashkia A, Jalilvand S, Mohajel N, Afchangi A, Azadmanesh K, Salehi-Vaziri M, Fazlalipour M, Pouriayevali MH, Jalali T, Mousavi Nasab SD, Roohvand F, Shoja (2020). “Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects”. Reviews in Medical Virology n/a (n/a): e2183. doi:10.1002/rmv.2183. PMC 7646037. PMID 33594794.
Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccine
Wang H, Yang P, Liu K, Guo F, Zhang Y, Zhang G, Jiang C (February 2008). “SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway”. Cell Research 18 (2): 290–301. doi:10.1038/cr.2008.15. PMC 7091891. PMID 18227861.
So AD, Woo J (December 2020). “Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis”. BMJ 371: m4750. doi:10.1136/bmj.m4750. PMC 7735431. PMID 33323376. cited "Agreements with CEPI and Gavi and the Serum Institute of India will bring vaccine to low and middle-income countries and beyond" (Press release). AstraZeneca. 4 June 2020.

pmc.ncbi.nlm.nih.gov

Arashkia A, Jalilvand S, Mohajel N, Afchangi A, Azadmanesh K, Salehi-Vaziri M, Fazlalipour M, Pouriayevali MH, Jalali T, Mousavi Nasab SD, Roohvand F, Shoja (2020). “Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects”. Reviews in Medical Virology n/a (n/a): e2183. doi:10.1002/rmv.2183. PMC 7646037. PMID 33594794.
Wang H, Yang P, Liu K, Guo F, Zhang Y, Zhang G, Jiang C (February 2008). “SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway”. Cell Research 18 (2): 290–301. doi:10.1038/cr.2008.15. PMC 7091891. PMID 18227861.
So AD, Woo J (December 2020). “Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis”. BMJ 371: m4750. doi:10.1136/bmj.m4750. PMC 7735431. PMID 33323376. cited "Agreements with CEPI and Gavi and the Serum Institute of India will bring vaccine to low and middle-income countries and beyond" (Press release). AstraZeneca. 4 June 2020.

nih.gov

“Phase 3 Clinical Testing in the US of AstraZeneca COVID-19 Vaccine Candidate Begins”. National Institutes of Health (NIH) (30 August 2020). 1 September 2020閲覧。

nikkei.com

「アストラゼネカ、新型コロナウイルスワクチンAZD1222の日本における製造販売承認を厚生労働省に申請」日本経済新聞 2021年2月5日付、2021年3月1日閲覧.

nytimes.com

ox.ac.uk

“Oxford team to begin novel coronavirus vaccine research”. University of Oxford (2020年2月7日). 2020年11月28日閲覧。
“Oxford team to begin novel coronavirus vaccine research”. University of Oxford. 2021年1月2日閲覧。
"Oxford University breakthrough on global COVID-19 vaccine". University of Oxford (Press release). 23 November 2020. 2021年1月12日閲覧。

posttoday.com

“ครม.ไฟเขียวงบซื้อวัคซีนโควิดเพิ่ม35ล้านโดส ฉีดให้คนไทย66ล้าน” (タイ語). โพสต์ทูเดย์ 2021年1月5日閲覧。

repubblica.it

“Pascal Soriot: "There are a lot of emotions on vaccines in EU. But it's complicated"” (イタリア語). la Repubblica (2021年1月26日). 2021年1月27日閲覧。

reuters.com

reuters.com

jp.reuters.com

「インド、近隣6カ国へのワクチン無償提供を開始」ロイター 2021年1月21日付、2021年3月1日閲覧.
“欧州当局、アストラ製ワクチン副反応にギラン・バレー症候群追加”. ロイター (2021年9月8日). 2021年9月9日閲覧。

uk.reuters.com

Reuters Staff (23 September 2020). “U.S. health secretary says AstraZeneca trial in United States remains on hold: CNBC”. Reuters 24 September 2020閲覧。

in.reuters.com

Prusty N, Jamkhandikar S (1 January 2021). “India drug regulator approves AstraZeneca COVID vaccine, country's first - sources”. Reuters

rte.ie

“AstraZeneca-Oxford vaccine can be used for people aged over 65 - WHO”. (10 February 2021) 12 February 2021閲覧。

statnews.com

“AstraZeneca Covid-19 vaccine study is put on hold”. Stat (8 September 2020). 10 September 2020閲覧。
“AstraZeneca Covid-19 vaccine study is put on hold” (8 September 2020). 2022年2月22日閲覧。

swissinfo.ch

“Swiss sign next vaccine agreement with AstraZeneca”. SWI swissinfo.ch. 16 October 2020閲覧。

ten-navi.com

answers.ten-navi.com

前田雄樹「好結果相次ぐ新型コロナワクチン、ゲームチェンジャーはどこか」 AnswersNews 2020年11月24日付、2021年3月1日閲覧.

tga.gov.au

ebs.tga.gov.au

https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/ViewPortalDoc?OpenAgent&?unid=CA257A1E003D918FCA25867F000004C6

tga.gov.au

“COVID-19 Vaccine AstraZeneca”. Therapeutic Goods Administration (TGA) (16 February 2021). 16 February 2021閲覧。

thairath.co.th

“ข่าวดี ไทยเริ่มผลิตวัคซีน 'โควิด-19' ในประเทศ รอบที่ 2 แล้ว”. ไทยรัฐออนไลน์. (2021年1月3日)

thedailystar.net

theguardian.com

thehill.com

Coleman J (10 June 2020). “Final testing stage for potential coronavirus vaccine set to begin in July”. TheHill. 11 June 2020閲覧。

thelancet.com

“Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet”. 9 December 2020閲覧。 This article incorporates text by Voysey et al. available under the CC BY 4.0 license.

thestandard.co

“สธ. แจง AstraZeneca เป็นผู้คัดเลือก Siam Bioscience ผลิตวัคซีนราคาทุน ขายถูกสุดในตลาด โต้ธนาธร ไม่ได้แทงม้าตัวเดียว”. THE STANDARD. (2021年1月19日)

uol.com.br

noticias.uol.com.br

Sabóia G, Mazieiro G, de Andrade H, Adorno L (2021年1月17日). “Anvisa aprova uso emergencial das vacinas CoronaVac e AstraZeneca no Brasil” [Anvisa approves emergency use of the CoronaVac and AstraZeneca vaccines in Brazil] (ポルトガル語). UOL. 2021年1月17日閲覧。

upi.com

Maresca T (2021年2月10日). “South Korea approves AstraZeneca COVID-19 vaccine” (英語). UPI 2021年2月10日閲覧。

vox.com

Belluz J (23 November 2020). “Why the AstraZeneca-Oxford Covid-19 vaccine is different”. Vox. 26 November 2020閲覧。

web.archive.org

Walsh N, Shelley J, Duwe E, Bonnett W (27 July 2020). “The world's hopes for a coronavirus vaccine may run in these health care workers' veins”. CNN (São Paulo). オリジナルの3 August 2020時点におけるアーカイブ。 3 August 2020閲覧。
“Investigating a Vaccine Against COVID-19”. ClinicalTrials.gov. United States National Library of Medicine (26 May 2020). 11 October 2020時点のオリジナルよりアーカイブ。14 July 2020閲覧。
“A Phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19”. EU Clinical Trials Register. European Union (21 April 2020). 5 October 2020時点のオリジナルよりアーカイブ。3 August 2020閲覧。
“ข่าวดี! ไทยจองซื้อวัคซีนโควิด-19 แอสตราเซเนกา "ราคาต้นทุน"”. hfocus.org (2020年11月23日). 2020年11月23日時点のオリジナルよりアーカイブ。2022年2月22日閲覧。

wikipedia.org

en.wikipedia.org

“COVID-19 Vaccine AstraZeneca EPAR”. European Medicines Agency (EMA). 2021年2月22日閲覧。
"European Commission authorises third safe and effective vaccine against COVID-19". European Commission (Press release). 2021年1月29日閲覧。
“Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca”. Medicines and Healthcare products Regulatory Agency (MHRA) (30 December 2020). 4 January 2021閲覧。
“Conditions of Authorisation for COVID-19 Vaccine AstraZeneca”. Medicines and Healthcare products Regulatory Agency (MHRA) (30 December 2020). 4 January 2021閲覧。
“COVID-19 Vaccine AstraZeneca”. Therapeutic Goods Administration (TGA) (16 February 2021). 16 February 2021閲覧。
Walsh N, Shelley J, Duwe E, Bonnett W (27 July 2020). “The world's hopes for a coronavirus vaccine may run in these health care workers' veins”. CNN (São Paulo). オリジナルの3 August 2020時点におけるアーカイブ。 3 August 2020閲覧。
“Investigating a Vaccine Against COVID-19”. ClinicalTrials.gov. United States National Library of Medicine (26 May 2020). 11 October 2020時点のオリジナルよりアーカイブ。14 July 2020閲覧。
"AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19". Press Release (Press release). AstraZeneca. 23 November 2020. 2021年1月5日閲覧。
“AstraZeneca Covid-19 vaccine study is put on hold”. Stat (8 September 2020). 10 September 2020閲覧。
Loftus P (13 September 2020). “AstraZeneca Covid-19 Vaccine Trials Resume in U.K.”. The Wall Street Journal 13 September 2020閲覧。
"COVID-19 Vaccine AstraZeneca confirms 100% protection against severe disease, hospitalisation and death in the primary analysis of Phase III trials". Press Release (Press release). AstraZeneca. 3 February 2021. 2021年2月18日閲覧。
Sabóia G, Mazieiro G, de Andrade H, Adorno L (2021年1月17日). “Anvisa aprova uso emergencial das vacinas CoronaVac e AstraZeneca no Brasil” [Anvisa approves emergency use of the CoronaVac and AstraZeneca vaccines in Brazil] (ポルトガル語). UOL. 2021年1月17日閲覧。
Belluz J (23 November 2020). “Why the AstraZeneca-Oxford Covid-19 vaccine is different”. Vox. 26 November 2020閲覧。
Stevis-Gridneff M, Sanger-Katz M, Weiland N (18 December 2020). “A European Official Reveals a Secret: The U.S. Is Paying More for Coronavirus Vaccines”. The New York Times 2020年12月19日閲覧。
So AD, Woo J (December 2020). “Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis”. BMJ 371: m4750. doi:10.1136/bmj.m4750. PMC 7735431. PMID 33323376. cited "Agreements with CEPI and Gavi and the Serum Institute of India will bring vaccine to low and middle-income countries and beyond" (Press release). AstraZeneca. 4 June 2020.
So & Woo (2020), p. 3 cited "New collaboration makes further 100 million doses of COVID-19 vaccine available to low- and middle- income countries" (Press release). Gavi, the Vaccine Alliance. 29 September 2020.^{[リンク切れ]}
“AstraZeneca vaccine approved, 50,000 doses due in February”. Bangkok Post. (2021年1月21日)
“FDA approves AstraZeneca”. Bangkok Post. (2021年1月22日)

wits.ac.za

“Latest - Oxford Covid-19 vaccine trial results - Wits University”. www.wits.ac.za. 2021年2月8日閲覧。

worldcat.org

search.worldcat.org

wsj.com

yna.co.kr

en.yna.co.kr

Kim HJ (2021年2月10日). “S. Korea approves AstraZeneca's COVID-19 vaccine for all adults” (英語). Yonhap News Agency 2021年2月10日閲覧。